New pill targets Tough-to-Treat lung cancer in groundbreaking trial
Disease control
Recruiting now
This study is testing a new oral medication called TRI-611 for adults with advanced ALK-positive non-small cell lung cancer. The first part aims to find a safe and effective dose, while the second part will see how well the drug works in different groups of patients based on thei…
Phase: PHASE1, PHASE2 • Sponsor: TRIANA Biomedicines, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC